Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
Introduction: Opioid overdose deaths continue to rise despite available safe and efficacious treatments for opioid use disorder, such as buprenorphine. Whereas provider-level access to buprenorphine has improved, community pharmacy-level barriers remain, related to patient stigma and regulatory conc...
Saved in:
| Main Authors: | Winter Roth, PharmD, BCPP, David Dadiomov, PharmD, BCPP |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association of Psychiatric Pharmacists
2025-04-01
|
| Series: | Mental Health Clinician |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.04.043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Suicide risk identification and mitigation in patients with chronic pain prescribed opioid medication
by: Dana L. Chiulli, PharmD, BCPP
Published: (2024-12-01) -
Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study
by: Joel Sprunger, et al.
Published: (2024-12-01) -
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
by: Pouya Azar, et al.
Published: (2025-05-01) -
Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis
by: Aline Lott, et al.
Published: (2025-04-01)